About EVA Pharma

EVA Pharma is a global healthcare company operating across 70+ countries, dedicated to addressing unmet patients’ needs through cutting-edge research & innovation. The company boasts 2 research centers gathering first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.

In favor of its internationally accredited facilities and 5000+ professionals, EVA Pharma produces 1 million medicines daily, adhering to rigorous international standards.

Committed to bridging healthcare gaps globally, EVA Pharma expands its operations across the world, including Africa, particularly establishing key legal entities in Kenya and Nigeria and forging partnerships with key pharmaceutical companies. The company has a goal to enhance access to quality insulin for 30 million individuals annually living in limited-resource settings areas by 2030. Recently, it has worked to develop its vaccine- and API-manufacturing capacity, to bring essential novel healthcare technologies and products to Africa.